Assessing Chemo-Radiotherapy Induced Toxicity and Quality of Life of Cancer Patients
Chemotherapy and radiotherapy are one of the major
treatment modalities that play important role in the management of a
number of different cancers. This study for the first time evaluates the
toxicity of these treatment modalities and its impact on quality of life
of cancer patients in Pakistan. The study also for the first time
determines what cancer patients of different ages and cancer stages
believe would be an effective intervention to manage their
psychosocial needs and treatment induced toxicity. The article also
provides evidence based approach for the use of variety of
interventions to mange cancer treatment induced morbidity and
toxicity. In light of the present study and reviewed research data,
evidence based recommendations are also made for selection of
appropriate interventions to manage Pain, Nausea and Vomiting,
Anxiety and Depression, Fatigue and Overall QOL of cancer
survivors.
[1] International Agency for Research on Cancer and WHO Press release
No 223, “Latest World Cancer statistics,” 2013. Available at:
http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf. (Accessed
02/01/2015)
[2] Cancer Therapy Evaluation Program, “Common Toxicity Criteria Ver
2,” 1999. Available at: http://prevention.cancer.gov/files/clinicaltrials/
common-toxicity-criteria.pdf. (Accessed 25/12/2014)
[3] Quality Health, “Radiotherapy Patient Experience Survey 2013 National
Report,” 2013. Available at: http://www.sor.org/system/files/news_story/201401/radiotherapy_patient_experience_survey_2013_nati
onal_report.pdf. (Accessed 25/12/2014).
[4] C. Booth, M. Clemon, G. BPharm, A. Joy, S. Young, W. Callaghan, et
al., “Chemotherapy Induced Nausea and Vomiting in Breast Cancer
Patients: A prospective Observational study,” The Journal of Supportive
Oncology, 5, 374-380, 2007.
[5] P. Chambers, and S. Daniels, “Antiemetic Guidelines for Adult Patients
receiving Chemotherapy and Radiotherapy,” 2010. Available at:
http://www.londoncancer.org/media/65597/antiemetic-guidelinesnovember-
2010.pdf. (Accessed 25/12/2014).
[6] A. Bhal, D. Sharma, P. Julka, and G. Rath, “Chemotherapy related
toxicity in locally advanced non-small cell lung cancer,” Journal of
Cancer Research and Therapeutics, 2, 14-16, 2006. Available at:
http://www.cancerjournal.net/article.asp?issn=0973-1482;
year=2006;volume=2;issue=1;spage=14;epage=16;aulast=Bahl.
(Accessed 25/12/2014).
[7] A. Nowak, M. Stockler, and M. Byrne, “Assessing Quality of Life
during chemotherapy for Pleural Mesothelioma: Feasibility, Validity and
Results of Using the European Organization for Research and Treatment
of Cancer Core Quality of Life questionnaire and Lung Cancer Module,”
Journal of Clinical Oncology., 22, 3172-3180, 2004.
[8] W. Pril, “Evidence report on the occurrence, assessment, and treatment
of depression in cancer patients,” Journal of the National Cancer
Institute. Monographs, 32, 32–9, 2004.
[9] D. Stark, and A. House, “Anxiety in cancer patients,” British Journal of
Cancer, 83, 1261–7, 2000. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2408796/pdf/83-6691405a.pdf. (Accessed
25/12/2014)
[10] D. Cella, K. Davis, W. Breitbart G. Curl, and Fatigue Coalition,
“Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a
United States sample of cancer survivors,” Journal of Clinical
Oncology, 19, 3385–3391, 2001.
[11] P. G. Fine, “The evolving and important role of anesthesiology in
palliative care,” Anesthesia Analgesia, 100,183–188, 2005.
[12] WHO, “WHO’s Cancer Pain ladder for adults,” Available at:
http://www.who.int/cancer/palliative/painladder/en/. (Accessed
9/12/2014).
[13] G. Pharo, and D. Zhou, “Pharmacological Management of Pain,” JAOA,
105, S21-S28, 2005.
[14] M. Lema, “Invasive procedures for cancer pain,” Pain Clin Update, 6, 1-
8, 1998.
[15] Y. Kanpolat, “Percutaneous destructive pain procedures on the upper
spinal cord and brain stem in cancer pain: CT-guided techniques,
indications and results,” Advances and Technical Standards in
Neurosurgery, 32, 147-73, 2007.
[16] R. Miguel, “Interventional treatment of cancer pain: The Fourth Step in
the World Health Organization Analgesic Ladder?,” Cancer Control, 7,
149-56, 2000. Available at: http://www.medscape.com/
viewarticle/408976. (Accessed 9/12/2014)
[17] G. Vargas-Schaffer, “Is the WHO Analgesic ladder still valid?,”
Canadian Family Physician, 56, 514-7, 2010. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902929/ Accessed
9/12/2014
[18] D. Carr, L. Goudas, E. Balk, R. Bloch, J. Ionnidis, and J. Lau, “Evidence
report on the treatment of pain in cancer patients,” Journal of the
National Cancer Institute. Monographs, 32, 23–31, 2004.
[19] E. Dunteman, “Levetiracetam as an adjunctive analgesic in neoplastic
plexopathies: case series and commentary,” Journal of Pain & Palliative
Care Pharmacotherapy, 19, 35–43, 2005.
[20] H. Adriaensen, K. Plaghki, C. Mathieu, A. Joffro, and K. Vissers,
“Critical review of oral drug treatments for diabetic neuropathic pain—
clinical outcomes based on efficacy and safety data from placebocontrolled
and direct comparative studies,” Diabetes Metab Res Rev, 21,
231–240, 2005.
[21] P. Demoly, and K. Chung, “Pharmacology of corticosteroids,” Respir
Med, 92, 385–394, 1998.
[22] L. Pujol, and D. Monti, “Managing Cancer Pain with Non
Pharmacologic and Complimentary Therapies,” JAOA., 107, ES15-ES21
[23] S. Willick, S. Herring, and J. Press, “Basic concepts in biomechanics
and musculoskeletal rehabilitation,” In: J. Loeser, S. Bugler, C.
Chapman, C. Turk, eds. Bonica’s Management of Pain. 3rd ed.
Philadelphia, Pa: Lippincott Williams & Wilkins; 2001, 1815-1831.
[24] T. Field, “Massage therapy effects,” The American Psychologist,
53,1270-1281, 1998.
[25] S. Weinrich, and M. Weinrich, “The effect of massage on pain in cancer
patients,” Applied Nursing Research. 3, 140-145, 1990.
[26] M. Falkensteiner, F. Mantovan, I. Muller, and C. Them, “The Use of
Message Therapy for reducing pain, Anxiety and depression in
Oncological palliative care patients: A narrative review of the
Literature,” International Scholarly Research Network Nursing, 2011
Available at: http://www.hindawi.com/journals/isrn/2011/929868/.
Accessed 11/12/2014.
[27] D. Wilkie, J. Kampbell, S. Cutshall et al., “Effects of massage on pain
intensity, analgesics and quality of life in patients with cancer pain: a
pilot study of a randomized clinical trial conducted within hospice care
delivery,” The Hospice Journal, 15, pp. 31–53, 2000.
[28] A. Cassileth and A. Vickers, “Massage therapy for symptom control:
outcome study at a major cancer center,” Journal of Pain and Symptom
Management, 28, pp. 244–249, 2004.
[29] J. Kutner, M. Smith, L. Corbin, L. Hemphill, K. Benton, B. Mellis, et al.,
“Massage therapy versus simple touch to improve pain and mood in
patients with advanced cancer: a randomized trial,” Annals of Internal
Medicine, 149, 369–379, 2008. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631433/. (Accessed
26/12/2014)
[30] L. Downey, P. Diehr, L. Standish D. Patrick, L. Kozak, D. Fisher et al.,
“Might massage or guided meditation provide “means to a better end”?
Primary outcomes from an efficacy trial with patients at the end of life,”
Journal of Palliative Care, 25, 2, 100–108, 2009. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858762/pdf/nihms-
189022.pdf. (Accessed 26/12/2014)
[31] N. Russell, S. Sumler, C. Beinhorn, and M. Frenkel, “Role of massage
therapy in cancer care,” The Journal of Alternative and Complementary
Medicine, 14, 209– 214, 2008.
[32] S. Nagele and A. Feichtner, “Lehrbuch der Palliativpflege,” Facultas,
Wien, Austria, 2005
[33] “Integration of behavioural and relaxation approaches into the treatment
of chronic pain and insomnia. NIH Technology Assessment Panel on
Integration of Behavioural and Relaxation Approaches into the
Treatment of Chronic Pain and Insomnia,” JAMA, 276, 313-318, 1996.
[34] G. Montgomery, C. Weltz, M. Seltz, and D. Bovbjerg, “Brief presurgery
hypnosis reduces distress and pain in excisional breast biopsy patients,”
The International Journal of Clinical and Experimental Hypnosis, 50,
17-32, 2002.
[35] International Association for the Study of Pain, “Global Year against
Pain, Psychosocial Interventions for Cancer Pain,” 2008. Available at:
http://www.iasppain.org/files/Content/ContentFolders/GlobalYearAgain
stPain2/CancerPainFactSheets/PsychosocialInterventions_Final.pdf.
(Accessed 11/12/2014)
[36] F. Keefe, A. Abernethy, and L. Campbell, “Psychological approaches to
understanding and treating disease-related pain,” Annu Rev Psychol,
56:601-630, 2005.
[37] A. Miaskowski, M. Dodd, C. West, K. Schumacher, S. Paul, D.
Tripathy, and P. Koo, “Randomized clinical trial of the effectiveness of
a self-care intervention to improve cancer pain management,” Journal of
Clinical Oncology, 22, 1713–20, 2004.
T. Rustoen, B. Valeberg, E. Kolstad, E. Wist, S. Paul, and C.
Miaskowski, “A randomized clinical trial of the efficacy of a self care
Intervention to improve cancer pain management,” Cancer Nursing, 37,
34-43, 2014.
[38] T. Rustoen, B. Valeberg, E. Kolstad, E. Wist, S. Paul, and C.
Miaskowski, “A randomized clinical trial of the efficacy of a self care
Intervention to improve cancer pain management,” Cancer Nursing, 37,
34-43, 2014.
[39] A. Abernethy, F. Keefe, D. McCrory, C. Scipio, and D. Matchar,
“Behavioral therapies for the management of cancer pain: a systematic
review,” In: H. Flor, E. Kalso, J. Dostrovsky, editors. Proceedings of the
11th World Congress on Pain. Seattle: IASP Press, 2006, 789–798
[40] J. Dalton, F. Keefe, J. Carlson, and R. Youngblood, “Tailoring
cognitive-behavioural treatment for cancer pain,” Pain Management
Nursing, 5, 3–18, 2004.
[41] A. Liossi, and P. Hatira, “Clinical hypnosis versus cognitive behavioural
training for pain management with pediatric cancer patients undergoing
bone marrow aspirations,” The International Journal of Clinical and
Experimental Hypnosis, 47, 104–16, 1999.
[42] C. Liossi, and P. Hatira, “Clinical hypnosis in the alleviation of
procedure-related pain in pediatric oncology patients,” The International
Journal of Clinical and Experimental Hypnosis, 51:4–28, 2003. [43] A. Spiegel, and J. Bloom, “Group therapy and hypnosis reduce
metastatic breast carcinoma pain,” Psychosomatic Medicine, 45, 333–9,
1983. Available at: http://bscw.rediris.es/pub/bscw.cgi/d4999766/
Spiegel-Group_therapy_hypnosis_reduce_metastatic_breast_carcinoma_
pain.pdf. (Accessed 26/12/2014).
[44] K. Syrjala, G. Donaldson, M. Davis, M. Kippes, and J. Carr, “Relaxation
and imagery and cognitive-behavioral training reduce pain during cancer
treatment: a controlled clinical trial,” Pain, 1995, 63, 189–98, 1995.
[45] A. Wood, J. Sega, B. Lynch, and J. Roenn, “Mangement of intractable
Nausea and vomiting in patients at the end of life,” JAMA, 298, 1196-
1207, 2007.
[46] M. Kris, P. Hesketh, M. Somerfield, P. Feyer, R. Clark-snow, J. Koeller,
et al., “American Society of Clinical Oncology guideline for antiemetics
in oncology: update 2006,” Journal of Clinical Oncology, 24, 2932-
2947, 2006. Available at: http://jco.ascopubs.org/content/
24/18/2932.full.pdf. (Accessed 26/12/2014)
[47] J. Roberts, and T. Priestman, “A review of ondansetron in the
management of radiotherapy- induced emesis,” Oncology, 50, 173-179,
1993.
[48] T. Gan, T. Meyer, C. Apfel, F. Chung, P. Davis, S. Eubanks, et al.,
“Consensus guidelines for managing postoperative nausea and
vomiting,” Anesthesia and Analgesia, 97, 62-71, 2003.
[49] K. Mystakidou, S. Befon, C. Liossi, and L. Vlacho, “Comparison of
tropisetron and chlorpromazine combinations in the control of nausea
and vomiting of patients with advanced cancer,” J Pain Symptom
Manage, 15, 176-184, 1998.
[50] R. Cole, F. Robinson, L. Harvey, K. Trethowan, and V. Murdoch, “
Successful control of intractable nausea and vomiting requiring
combined ondansetron and haloperidol in a patient with advanced
cancer,” J Pain Symptom Manage, 9, 48-50, 1994.
[51] S. Grunberg, R. Deuson, P. Mavros, O. Geling, M. Hansen, G. Cruciani
et al., “Incidence of chemotherapy induced nausea and emesis after
modern antiemetics,” Cancer, 100, 2261-2268, 2004. Available at:
http://onlinelibrary.wiley.com/doi/10.1002/cncr.20230/pdf. (Accessed
26/12/2014)
[52] D. Theobald, K. Kirsh, E. Holtsclaw, K. Donaghy, and S. Passik, “An
open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer
patients with pain and other distressing symptoms,” J Pain Symptom
Manage, 23, 442-447, 2002.
[53] A. Malik, W. Khan, M. Qazilbash, E. Ata, A. Butt, and M. Khan,
“Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and
delayed nausea and vomiting induced by high doses of cisplatin,”
American Journal of Clinical Oncology, 18, 170-175, 1995.
[54] S. Simms, V. Rhodes, and R. Madsen, “Comparison of prochlorperazine
and lorazepam antiemetic regimens in the control of postchemotherapy
symptoms,” Nursing Research, 42, 234-239, 1993.
[55] T. Priestman, J. Roberts, H. Lucraft, C. Collis, M. Adams, B.
Upadhyaya et al., “Results of a randomized, double blind comparative
study of ondansetron and metoclopramide in the prevention of nausea
and vomiting following high-dose upper abdominal irradiation,” Clinical
Oncology (R Coll Radiol), 2, 71-75, 1990.
[56] M. Burmeister, T. Standl, M. Wintruff, P. Brauer, I. Blanc, J. Schulte am
Esch, “Dolasetron prophylaxis reduces nausea and postanaesthesia
recovery time after remifentanil infusion during monitored anaesthesia
care for extracorporeal shock wave lithotripsy,” Br J Anaesth, 90, 194-
198, 2003.
[57] B. Brücher, H. Stein, H. Bartels, H. Feussner, J. Siewert, “Achalasia and
esophageal cancer: incidence, prevalence, and prognosis,” World
Journal of Surgery, 25, 745-749, 2001.
[58] M. Gupta, M. Davis, S. LeGrand, D. Welsh, R. Lagman, “Nausea and
Vomiting in Advanced cancer: the Cleveland Clinic Protocol,” The
Journal of Supportive Oncology, 11, 8-13, 2013.
[59] D. Salvia, P. Reis, I. Gomes, S. Funghetto, C. Leon, “Non
Pharmacological Interventions for chemotherapy Induced Nausea and
Vomits: Integrated review,” Online Brazilian Journal of Nursing, 8,
2009. Available at: http://www.objnursing.uff.br/index.php/
nursing/article/view/j.1676-4285.2009.2098/463 (8/12/2014).
[60] A. Marchioro, G. Azzarello, F .Viviani, F. Barbato, M. Pavanetto, F.
Rosetti F, et al., “Hypnosis in the Treatment of Anticipatory Nausea and
Vomiting in Patients Receiving Cancer Chemotherapy,” Oncology, 59
100-104, 2000.
[61] R. Raghavendra, R. Nagarathna, H. Nagendra, K. Gopinath, B. Srinth,
B. Ravi, et al., “Effects of an integrated yoga program on chemotherapyinduced
nausea and emesis in breast cancer Patients,” European Journal
of Cancer Care, 16, 462-474, 2007.
[62] A. Slevin, S. Nichols, S. Downer, P. Wilson, T. Lister, S. Arnott, et al.,
“Emotional support for cancer patients: What do patients really want?,”
British Journal of Cancer, 74, 1275-1279, 1996.
[63] K. Jamison, D. Wellisch, and R. Pasnau, “Psychosocial Aspects of
mastectomy: 1. The women’s perspective,” The American. Journal of
Psychiatry,, 34, 432-436, 1978.
[64] C. Dunkel-Schetter, “Social Support and Cancer: Findings based on
patient interviews and their implications,” Journal of Social Issues, 40,
77-98, 1984.
[65] R. Chlebowski, G. Blackburn, C. Thomson, D. Nixon, A. Shapiro, M.
Hoy, et al., “Dietary fat reduction and breast cancer outcome: Interim
efficacy results from the Women’s Intervention Nutrition Study,”.
Journal of the National Cancer Institute, 98, 1767-76, 2006.
[66] J. Pierce, L. Natarajan, B. Caan, B. Parker, E. Greenberg, S. Flatt, et al.,
“Influence of a Diet Very High in Vegetables, Fruit, and Fibre and Low
in Fat on Prognosis Following Treatment for Breast Cancer: The
Women’s Healthy Eating and Living (WHEL) Randomized Trial,”
JAMA, 18, 289-98, 2007. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2083253/. (Accsessed 8/12/2014)
[67] Y. Lee, S. Lee, J. Choi, M. Song, H. Sung, S. Jeon, et al., “Prognosis of
breast cancer is associated with one carbon metabolism related nutrients
among Korean women,” Nutrition Journal, 11, 1-9, 2012. Available at:
http://www.nutritionj.com/content/pdf/1475-2891-11-59.pdf. (Accessed
8/12/2014).
[68] A. Harris, L. Bergkvist, and A. Wolk, “Folate intake and breast cancer
mortality in a cohort of Swedish women,” Breast Cancer Research and
Treatment, 132, 243–250, 2011. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747350/. (Accessed
26/12/2014)
[69] M. Holmes, M. Stampfer, G. Colditz, B. Rosner, D. Hunter, and W.
Willett, “Dietary factors and the survival of women with breast
carcinoma,” Cancer, 86, 826–835, 1999.
[70] E. Rossi, J. Hung, J. Beilby, M. Knuiman, M. Divitini, and H.
Bartholomew, “Folate levels and cancer morbidity and mortality:
prospective cohort study from Busselton, Western Australia,” Annals of
Epidemiology, 16, 206–212, 2006.
[71] Z. Guo, H. Tang, H. Li, S. Tan, K. Feng, Y. Huang, et al., “The Benefits
of psychosocial interventions for Cancer patients undergoing
Radiotherapy,” Health and Quality of Life outcomes, 11, 1-12, 2013.
Available at: http://www.hqlo.com/content/pdf/1477-7525-11-121.pdf.
(Accessed 26/12/2014)
[72] P. Jacobsen, K. Donovan, Z. Swaine, et al., “Management of anxiety and
depression in adult cancer patients: toward an evidence-based
approach,” in A. Chang, P. Ganz, D. Hayes, et al., (eds). Oncology: An
Evidence-Based Approach. New York, NY: Springer-Verlag;
2006:1552–1579 Available at: http://www.cas.usf.edu/~jacobsen/
Anxiety%20depression%20review.pdf (Accessed 8/12/2014).
[73] A. Greer, L. Traeger, H. Bemis, J. Solis, E. Hendriksen, and E. Park, “A
Pilot randomized controlled Trial of Brief Cognitive Behavioural
Therapy for Anxiety in Patients with Terminal Cancer,” The Oncologist,
17, 1337-1345, 2012. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3481900/. (Accessed 26/12/2014)
[74] S. Moorey, E. Cort, M. Kapari B. Monroe, P. Hansford, K. Mannix, et
al., “A cluster randomized controlled trial of cognitive behaviour therapy
for common mental disorders in patients with advanced cancer,”
Psychological Medicine, 39, 713–723, 2009.
[75] D. Kissane, B. Grabsch, D. Clarke, G. Smith, A. Love, S. Bloch et al.,
“Supportive‑expressive group therapy for women with metastatic breast
cancer: survival and psychosocial outcome from a randomized
controlled trial 2,” Psychooncology, 16, 277–286, 2007.
[76] D. Spigel, L. Butler, J. Giese-Davis, C. Koopman, E. Miller, S. DiMiceli
et al., “Effects of supportive expressive group Therapy on survival of
patients with metastatic breast cancer,” Cancer, 110, 1130-1138, 2007.
Available at: http://onlinelibrary.wiley.com/doi/10.1002/cncr.22890/full.
(Accessed 25/12/2014)
[77] National Breast Cancer Centre and National Cancer Control Initiative,
“Clinical Practice Guidelines for the psychosocial care of adults with
cancer,” 2003.
[78] M. Holmes, W. Chen, D. Feskanich, C. Kroenke, and G. Colditz,
“Physical activity and survival after breast cancer diagnosis,” JAMA, 25,
293:2479-86, 2005.
[79] A. Meyerhardt, E. Giovannucci, M. Holmes, A. Chan, J. Chan, G.
Colditz, et al, “Physical Activity and Survival After Colorectal Cancer
Diagnosis,” J Clin Oncol, 1, 3527-34, 2006.[80] C. Holick, P. Newcomb, A. Trentham-Dietz, L. Titus-Ernstoff, A.
Bersch, M. Stampfer, et al, “Physical Activity and Survival after
Diagnosis of Invasive Breast Cancer,” Cancer Epidemiology,
Biomarkers & Prevention, 1, 379-86, 2008.
[81] M. Irwin, A. Smith, A. McTiernan, R. Ballard-Barbash, K. Cronin, F.
Gilliland, et al., “Influence of Pre- and Postdiagnosis Physical Activity
on Mortality in Breast Cancer Survivors: The Health, Eating, Activity,
and Lifestyle Study,” Journal of Clinical Oncology, 20, 3958-64, 2008.
[82] Daley, H. Crank, J. Saxton,N. Mutrie, R. Coleman, and A. Roalfe et al.,
“Randomized trial of Exercise Therapy in Women Treated with Breast
Cancer”, Journal of Clinical Oncology, 25, 13, 2007. Available at:
http://jco.ascopubs.org/content/25/13/1713.long. (Accessed 25/12/2014).
[83] Courneya, R. Segal, J. Mackey, K. Gelmon, R. Reid, C. Friedenreich, et
al., “Effects of Aerobic and Resistance Exercise in Breast Cancer
Patients receiving Adjuvant Chemotherapy: A Multicentre Randomized
Controlled Trial,” Journal of Clinical Oncology, 25, 4396-4404, 2007.
[84] Courneya, J. Mackey, G. Bell, L. Jones, C. Field, and A. Fairey,
“Randomized controlled trial of exercise training in postmenopausal
breast cancer survivors: Cardiopulmonary and quality of life outcomes,”
Journal of Clinical Oncology, 21, 1660-1668, 2003. Available at:
http://www.cebp.nl/media/m542.pdf. (Accessed 25/12/2014)
[85] P. Fobair, S. Stewart, S. Chang, C. Onofrio, P. Banks, and J. Bloom,
“Body image and sexual problems in young women with breast cancer,”
Psychooncology, 15, 579-594, 2006.
[86] McNeely, K. Campbell, B. Rowe, T. Klassen, J. Mackey, K. Courneya,
“Effects of Exercise on Breast Cancer Patients and Survivors; a
systematic review and meta-analysis,” CMAJ, 175, 34-41, 2006.
[87] V. Conn, A. Hafdahl, D. Porock, R. McDaniel, and P. Nielsen, “A meta
analysis of exercise interventions among people treated for cancer,”
Supportive Care in Cancer, 14, 699-712, 2006
[88] K. Schmitz, J. Holtzman, K. Courneya, L. Masse, S. Duval, R. Kane,
“Controlled physical activity trials in cancer survivors: A systematic
review and meta-analysis,” Cancer Epidemiology Biomarkers &
Prevention, 14, 1588-1595, 2005. Available at:
http://cebp.aacrjournals.org/content/14/7/1588.long. (Accessed
25/12/2014).
[89] A. Moadel, C. Shah, J. Wylie-Rosett, M. Harris, S. Patel, and C. Hall, et
al., “Randomized controlled Trial of Yoga among a multiethnic sample
of breast cancer patients: Effects on Quality of Life,” Journal of Clinical
Oncology, 25, 2007
[90] S. Culos-Reed, L. Carlson, L. Daroux, and S. Hately, “A pilot study of
yoga for breast cancer survivors:Physical and psychological benefits,”
Psychooncology, 15, 891-897, 2006.
[91] R. Segal, R. Reid, K. Courneya, R. Sigal, G. Kenny, D. Homme, et al.,
“Randomized Controlled Trial of Resistance or Aerobic Exercise in Men
Receiving Radiation Therapy for Prostate Cancer,” Journal of Clinical
Oncology, 27, 344-351, 2009.
[92] P. Windsor, K. Nicol, and J. Potter, “A randomized, controlled trial of
aerobic exercise for treatment related fatigue in men receiving radical
external beam radiotherapy for localized prostate carcinoma,” Cancer,
101, 550-557, 2004.
[93] Culos-Reed SN, Robinson JL, Lau H, K. O’Connor, and M. Keats,
“Benefits of a physical activity intervention for men with prostate
cancer,” Journal of Sport & Exercise Psychology, 29,118- 127, 2007
[94] B. Jereczek-Fossa, H. Marsiglia, and R. Orecchia, “Radiotherapy-related
fatigue,” Critical Reviews in Oncol Hematology, 41:317-325, 2002
[95] C. Bennett, S. Silver, B. Djulbegovic, A. Samaras, C. Blau, K. Gleason,
et al., “Venous thromboembolism and mortality associated with
recombinant erythropoietin and darbepoetin administration for the
treatment of cancer associated anemia,” JAMA, 299, 914-924, 2008.
[96] J. Lemieux, A. Topp, H. Chappell, M. Ennis, and P. Goodwin,
“Economic analysis of psychosocial group therapy in women with
metastatic breast cancer,” Breast Cancer Research and Treatment,
100,183-190, 2006.
[97] S. Hayes, R. Spence, D. Galvão, and R. Newton, “Australian
Association for Exercise and Sport Science position stand: Optimising
cancer outcomes through exercise,” Journal of Science and Medicine in
Sport, 12, 428-34, 2009.
[98] Minton, A. Berger A, A. Barsevick, F. Cramp, M. Goedendorp, S.
Mitchell, et al., “Cancer-related fatigue and its impact on functioning,”
Cancer, 119, 2124–30, 2013.
[99] L. Whitehead, “The measurement of fatigue in chronic illness: a
systematic review of unidimensional and multidimensional fatigue
measures,” J Pain Symptom Manage, 37, 107–28, 2009.
[100]A. Aaronson, V. Mattioli, O. Minton, J. Weis, C. Johansen, S. Dalton, et
al., “Beyond Treatment-Psychosocial and behavioural issues in cancer
survivorship research and practice,” EJC Supplements, 12, 54-64, 2014.
[101] W. Linden, and A. Girgis, “Psychological treatment outcomes for
cancer patients: what do meta-analyses tell us about distress reduction?,”
Psychooncology, 2012;21(4):343–50
[102] K. Boyes, L. Hodgkinson, Alridge, and J. Turner, “Issues for Cancer
Survivors in Australia,” Cancer Forum, 33, 164-167, 2009.
[103] J. Bloom, R. Hoppe, P. Fobair , R. Cox, A. Varghese, D. Spiegel,
“Effects of treatment on the work experiences of long-term survivors of
Hodgkin’s disease,” Journal of Psychosocial Oncology, 1989, 6, 65-80.
Available at: http://www.tandfonline.com/doi/abs/10.1300/
J077v06n03_05?journalCode=wjpo20#.VKZFuXtrJOY. (Accessed
02/01/2015)
[104]Wingard JR, Curbow B, Baker F, Piantadosi S. Health, functional status,
and employment of adult survivors of bone marrow transplantation. Ann
Intern Med. 1991;114:113-118.
[105]S. Schagen, M. Muller, W. Boogerd, G. Mellenbergh, and F. van Dam,
“Change in cognitive function after chemotherapy: a prospective
longitudinal study in breast cancer patients,” Journal of National Cancer
Institute, 98, 1742-1745, 2006. Available at:
http://jnci.oxfordjournals.org/content/98/23/1742.long. (Accessed
25/12/2014).
[106]D. Coward, “Supporting Health Promotion in Adults with Cancer,”
Family & Community Health, 19, 52S-60S, 2005.
[107]L. Forsythe, E. Kent, K. Weaver, N. Buchanan, N. Hawkins, J.
Rodriguez, “Receipt of Psychosocial care among Cancer Survivors in
the United States,” Journal of Clinical Oncology, 31, 1961-69.
[108]J. Guidry , L. Aday, D. Zhang, and R. Winn, “The role of informal and
formal social support networks for patients with cancer,” Cancer
Practice, 5, 241–246, 1997.
[109]A. Leis, C. Haines, and G. Pancyr, “Exploring oncologists’ beliefs about
psychosocial groups: implications for patient care and research,” Journal
of Psychosocial Oncology, 12, 77–87, 1994.
[1] International Agency for Research on Cancer and WHO Press release
No 223, “Latest World Cancer statistics,” 2013. Available at:
http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf. (Accessed
02/01/2015)
[2] Cancer Therapy Evaluation Program, “Common Toxicity Criteria Ver
2,” 1999. Available at: http://prevention.cancer.gov/files/clinicaltrials/
common-toxicity-criteria.pdf. (Accessed 25/12/2014)
[3] Quality Health, “Radiotherapy Patient Experience Survey 2013 National
Report,” 2013. Available at: http://www.sor.org/system/files/news_story/201401/radiotherapy_patient_experience_survey_2013_nati
onal_report.pdf. (Accessed 25/12/2014).
[4] C. Booth, M. Clemon, G. BPharm, A. Joy, S. Young, W. Callaghan, et
al., “Chemotherapy Induced Nausea and Vomiting in Breast Cancer
Patients: A prospective Observational study,” The Journal of Supportive
Oncology, 5, 374-380, 2007.
[5] P. Chambers, and S. Daniels, “Antiemetic Guidelines for Adult Patients
receiving Chemotherapy and Radiotherapy,” 2010. Available at:
http://www.londoncancer.org/media/65597/antiemetic-guidelinesnovember-
2010.pdf. (Accessed 25/12/2014).
[6] A. Bhal, D. Sharma, P. Julka, and G. Rath, “Chemotherapy related
toxicity in locally advanced non-small cell lung cancer,” Journal of
Cancer Research and Therapeutics, 2, 14-16, 2006. Available at:
http://www.cancerjournal.net/article.asp?issn=0973-1482;
year=2006;volume=2;issue=1;spage=14;epage=16;aulast=Bahl.
(Accessed 25/12/2014).
[7] A. Nowak, M. Stockler, and M. Byrne, “Assessing Quality of Life
during chemotherapy for Pleural Mesothelioma: Feasibility, Validity and
Results of Using the European Organization for Research and Treatment
of Cancer Core Quality of Life questionnaire and Lung Cancer Module,”
Journal of Clinical Oncology., 22, 3172-3180, 2004.
[8] W. Pril, “Evidence report on the occurrence, assessment, and treatment
of depression in cancer patients,” Journal of the National Cancer
Institute. Monographs, 32, 32–9, 2004.
[9] D. Stark, and A. House, “Anxiety in cancer patients,” British Journal of
Cancer, 83, 1261–7, 2000. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2408796/pdf/83-6691405a.pdf. (Accessed
25/12/2014)
[10] D. Cella, K. Davis, W. Breitbart G. Curl, and Fatigue Coalition,
“Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a
United States sample of cancer survivors,” Journal of Clinical
Oncology, 19, 3385–3391, 2001.
[11] P. G. Fine, “The evolving and important role of anesthesiology in
palliative care,” Anesthesia Analgesia, 100,183–188, 2005.
[12] WHO, “WHO’s Cancer Pain ladder for adults,” Available at:
http://www.who.int/cancer/palliative/painladder/en/. (Accessed
9/12/2014).
[13] G. Pharo, and D. Zhou, “Pharmacological Management of Pain,” JAOA,
105, S21-S28, 2005.
[14] M. Lema, “Invasive procedures for cancer pain,” Pain Clin Update, 6, 1-
8, 1998.
[15] Y. Kanpolat, “Percutaneous destructive pain procedures on the upper
spinal cord and brain stem in cancer pain: CT-guided techniques,
indications and results,” Advances and Technical Standards in
Neurosurgery, 32, 147-73, 2007.
[16] R. Miguel, “Interventional treatment of cancer pain: The Fourth Step in
the World Health Organization Analgesic Ladder?,” Cancer Control, 7,
149-56, 2000. Available at: http://www.medscape.com/
viewarticle/408976. (Accessed 9/12/2014)
[17] G. Vargas-Schaffer, “Is the WHO Analgesic ladder still valid?,”
Canadian Family Physician, 56, 514-7, 2010. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902929/ Accessed
9/12/2014
[18] D. Carr, L. Goudas, E. Balk, R. Bloch, J. Ionnidis, and J. Lau, “Evidence
report on the treatment of pain in cancer patients,” Journal of the
National Cancer Institute. Monographs, 32, 23–31, 2004.
[19] E. Dunteman, “Levetiracetam as an adjunctive analgesic in neoplastic
plexopathies: case series and commentary,” Journal of Pain & Palliative
Care Pharmacotherapy, 19, 35–43, 2005.
[20] H. Adriaensen, K. Plaghki, C. Mathieu, A. Joffro, and K. Vissers,
“Critical review of oral drug treatments for diabetic neuropathic pain—
clinical outcomes based on efficacy and safety data from placebocontrolled
and direct comparative studies,” Diabetes Metab Res Rev, 21,
231–240, 2005.
[21] P. Demoly, and K. Chung, “Pharmacology of corticosteroids,” Respir
Med, 92, 385–394, 1998.
[22] L. Pujol, and D. Monti, “Managing Cancer Pain with Non
Pharmacologic and Complimentary Therapies,” JAOA., 107, ES15-ES21
[23] S. Willick, S. Herring, and J. Press, “Basic concepts in biomechanics
and musculoskeletal rehabilitation,” In: J. Loeser, S. Bugler, C.
Chapman, C. Turk, eds. Bonica’s Management of Pain. 3rd ed.
Philadelphia, Pa: Lippincott Williams & Wilkins; 2001, 1815-1831.
[24] T. Field, “Massage therapy effects,” The American Psychologist,
53,1270-1281, 1998.
[25] S. Weinrich, and M. Weinrich, “The effect of massage on pain in cancer
patients,” Applied Nursing Research. 3, 140-145, 1990.
[26] M. Falkensteiner, F. Mantovan, I. Muller, and C. Them, “The Use of
Message Therapy for reducing pain, Anxiety and depression in
Oncological palliative care patients: A narrative review of the
Literature,” International Scholarly Research Network Nursing, 2011
Available at: http://www.hindawi.com/journals/isrn/2011/929868/.
Accessed 11/12/2014.
[27] D. Wilkie, J. Kampbell, S. Cutshall et al., “Effects of massage on pain
intensity, analgesics and quality of life in patients with cancer pain: a
pilot study of a randomized clinical trial conducted within hospice care
delivery,” The Hospice Journal, 15, pp. 31–53, 2000.
[28] A. Cassileth and A. Vickers, “Massage therapy for symptom control:
outcome study at a major cancer center,” Journal of Pain and Symptom
Management, 28, pp. 244–249, 2004.
[29] J. Kutner, M. Smith, L. Corbin, L. Hemphill, K. Benton, B. Mellis, et al.,
“Massage therapy versus simple touch to improve pain and mood in
patients with advanced cancer: a randomized trial,” Annals of Internal
Medicine, 149, 369–379, 2008. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631433/. (Accessed
26/12/2014)
[30] L. Downey, P. Diehr, L. Standish D. Patrick, L. Kozak, D. Fisher et al.,
“Might massage or guided meditation provide “means to a better end”?
Primary outcomes from an efficacy trial with patients at the end of life,”
Journal of Palliative Care, 25, 2, 100–108, 2009. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858762/pdf/nihms-
189022.pdf. (Accessed 26/12/2014)
[31] N. Russell, S. Sumler, C. Beinhorn, and M. Frenkel, “Role of massage
therapy in cancer care,” The Journal of Alternative and Complementary
Medicine, 14, 209– 214, 2008.
[32] S. Nagele and A. Feichtner, “Lehrbuch der Palliativpflege,” Facultas,
Wien, Austria, 2005
[33] “Integration of behavioural and relaxation approaches into the treatment
of chronic pain and insomnia. NIH Technology Assessment Panel on
Integration of Behavioural and Relaxation Approaches into the
Treatment of Chronic Pain and Insomnia,” JAMA, 276, 313-318, 1996.
[34] G. Montgomery, C. Weltz, M. Seltz, and D. Bovbjerg, “Brief presurgery
hypnosis reduces distress and pain in excisional breast biopsy patients,”
The International Journal of Clinical and Experimental Hypnosis, 50,
17-32, 2002.
[35] International Association for the Study of Pain, “Global Year against
Pain, Psychosocial Interventions for Cancer Pain,” 2008. Available at:
http://www.iasppain.org/files/Content/ContentFolders/GlobalYearAgain
stPain2/CancerPainFactSheets/PsychosocialInterventions_Final.pdf.
(Accessed 11/12/2014)
[36] F. Keefe, A. Abernethy, and L. Campbell, “Psychological approaches to
understanding and treating disease-related pain,” Annu Rev Psychol,
56:601-630, 2005.
[37] A. Miaskowski, M. Dodd, C. West, K. Schumacher, S. Paul, D.
Tripathy, and P. Koo, “Randomized clinical trial of the effectiveness of
a self-care intervention to improve cancer pain management,” Journal of
Clinical Oncology, 22, 1713–20, 2004.
T. Rustoen, B. Valeberg, E. Kolstad, E. Wist, S. Paul, and C.
Miaskowski, “A randomized clinical trial of the efficacy of a self care
Intervention to improve cancer pain management,” Cancer Nursing, 37,
34-43, 2014.
[38] T. Rustoen, B. Valeberg, E. Kolstad, E. Wist, S. Paul, and C.
Miaskowski, “A randomized clinical trial of the efficacy of a self care
Intervention to improve cancer pain management,” Cancer Nursing, 37,
34-43, 2014.
[39] A. Abernethy, F. Keefe, D. McCrory, C. Scipio, and D. Matchar,
“Behavioral therapies for the management of cancer pain: a systematic
review,” In: H. Flor, E. Kalso, J. Dostrovsky, editors. Proceedings of the
11th World Congress on Pain. Seattle: IASP Press, 2006, 789–798
[40] J. Dalton, F. Keefe, J. Carlson, and R. Youngblood, “Tailoring
cognitive-behavioural treatment for cancer pain,” Pain Management
Nursing, 5, 3–18, 2004.
[41] A. Liossi, and P. Hatira, “Clinical hypnosis versus cognitive behavioural
training for pain management with pediatric cancer patients undergoing
bone marrow aspirations,” The International Journal of Clinical and
Experimental Hypnosis, 47, 104–16, 1999.
[42] C. Liossi, and P. Hatira, “Clinical hypnosis in the alleviation of
procedure-related pain in pediatric oncology patients,” The International
Journal of Clinical and Experimental Hypnosis, 51:4–28, 2003. [43] A. Spiegel, and J. Bloom, “Group therapy and hypnosis reduce
metastatic breast carcinoma pain,” Psychosomatic Medicine, 45, 333–9,
1983. Available at: http://bscw.rediris.es/pub/bscw.cgi/d4999766/
Spiegel-Group_therapy_hypnosis_reduce_metastatic_breast_carcinoma_
pain.pdf. (Accessed 26/12/2014).
[44] K. Syrjala, G. Donaldson, M. Davis, M. Kippes, and J. Carr, “Relaxation
and imagery and cognitive-behavioral training reduce pain during cancer
treatment: a controlled clinical trial,” Pain, 1995, 63, 189–98, 1995.
[45] A. Wood, J. Sega, B. Lynch, and J. Roenn, “Mangement of intractable
Nausea and vomiting in patients at the end of life,” JAMA, 298, 1196-
1207, 2007.
[46] M. Kris, P. Hesketh, M. Somerfield, P. Feyer, R. Clark-snow, J. Koeller,
et al., “American Society of Clinical Oncology guideline for antiemetics
in oncology: update 2006,” Journal of Clinical Oncology, 24, 2932-
2947, 2006. Available at: http://jco.ascopubs.org/content/
24/18/2932.full.pdf. (Accessed 26/12/2014)
[47] J. Roberts, and T. Priestman, “A review of ondansetron in the
management of radiotherapy- induced emesis,” Oncology, 50, 173-179,
1993.
[48] T. Gan, T. Meyer, C. Apfel, F. Chung, P. Davis, S. Eubanks, et al.,
“Consensus guidelines for managing postoperative nausea and
vomiting,” Anesthesia and Analgesia, 97, 62-71, 2003.
[49] K. Mystakidou, S. Befon, C. Liossi, and L. Vlacho, “Comparison of
tropisetron and chlorpromazine combinations in the control of nausea
and vomiting of patients with advanced cancer,” J Pain Symptom
Manage, 15, 176-184, 1998.
[50] R. Cole, F. Robinson, L. Harvey, K. Trethowan, and V. Murdoch, “
Successful control of intractable nausea and vomiting requiring
combined ondansetron and haloperidol in a patient with advanced
cancer,” J Pain Symptom Manage, 9, 48-50, 1994.
[51] S. Grunberg, R. Deuson, P. Mavros, O. Geling, M. Hansen, G. Cruciani
et al., “Incidence of chemotherapy induced nausea and emesis after
modern antiemetics,” Cancer, 100, 2261-2268, 2004. Available at:
http://onlinelibrary.wiley.com/doi/10.1002/cncr.20230/pdf. (Accessed
26/12/2014)
[52] D. Theobald, K. Kirsh, E. Holtsclaw, K. Donaghy, and S. Passik, “An
open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer
patients with pain and other distressing symptoms,” J Pain Symptom
Manage, 23, 442-447, 2002.
[53] A. Malik, W. Khan, M. Qazilbash, E. Ata, A. Butt, and M. Khan,
“Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and
delayed nausea and vomiting induced by high doses of cisplatin,”
American Journal of Clinical Oncology, 18, 170-175, 1995.
[54] S. Simms, V. Rhodes, and R. Madsen, “Comparison of prochlorperazine
and lorazepam antiemetic regimens in the control of postchemotherapy
symptoms,” Nursing Research, 42, 234-239, 1993.
[55] T. Priestman, J. Roberts, H. Lucraft, C. Collis, M. Adams, B.
Upadhyaya et al., “Results of a randomized, double blind comparative
study of ondansetron and metoclopramide in the prevention of nausea
and vomiting following high-dose upper abdominal irradiation,” Clinical
Oncology (R Coll Radiol), 2, 71-75, 1990.
[56] M. Burmeister, T. Standl, M. Wintruff, P. Brauer, I. Blanc, J. Schulte am
Esch, “Dolasetron prophylaxis reduces nausea and postanaesthesia
recovery time after remifentanil infusion during monitored anaesthesia
care for extracorporeal shock wave lithotripsy,” Br J Anaesth, 90, 194-
198, 2003.
[57] B. Brücher, H. Stein, H. Bartels, H. Feussner, J. Siewert, “Achalasia and
esophageal cancer: incidence, prevalence, and prognosis,” World
Journal of Surgery, 25, 745-749, 2001.
[58] M. Gupta, M. Davis, S. LeGrand, D. Welsh, R. Lagman, “Nausea and
Vomiting in Advanced cancer: the Cleveland Clinic Protocol,” The
Journal of Supportive Oncology, 11, 8-13, 2013.
[59] D. Salvia, P. Reis, I. Gomes, S. Funghetto, C. Leon, “Non
Pharmacological Interventions for chemotherapy Induced Nausea and
Vomits: Integrated review,” Online Brazilian Journal of Nursing, 8,
2009. Available at: http://www.objnursing.uff.br/index.php/
nursing/article/view/j.1676-4285.2009.2098/463 (8/12/2014).
[60] A. Marchioro, G. Azzarello, F .Viviani, F. Barbato, M. Pavanetto, F.
Rosetti F, et al., “Hypnosis in the Treatment of Anticipatory Nausea and
Vomiting in Patients Receiving Cancer Chemotherapy,” Oncology, 59
100-104, 2000.
[61] R. Raghavendra, R. Nagarathna, H. Nagendra, K. Gopinath, B. Srinth,
B. Ravi, et al., “Effects of an integrated yoga program on chemotherapyinduced
nausea and emesis in breast cancer Patients,” European Journal
of Cancer Care, 16, 462-474, 2007.
[62] A. Slevin, S. Nichols, S. Downer, P. Wilson, T. Lister, S. Arnott, et al.,
“Emotional support for cancer patients: What do patients really want?,”
British Journal of Cancer, 74, 1275-1279, 1996.
[63] K. Jamison, D. Wellisch, and R. Pasnau, “Psychosocial Aspects of
mastectomy: 1. The women’s perspective,” The American. Journal of
Psychiatry,, 34, 432-436, 1978.
[64] C. Dunkel-Schetter, “Social Support and Cancer: Findings based on
patient interviews and their implications,” Journal of Social Issues, 40,
77-98, 1984.
[65] R. Chlebowski, G. Blackburn, C. Thomson, D. Nixon, A. Shapiro, M.
Hoy, et al., “Dietary fat reduction and breast cancer outcome: Interim
efficacy results from the Women’s Intervention Nutrition Study,”.
Journal of the National Cancer Institute, 98, 1767-76, 2006.
[66] J. Pierce, L. Natarajan, B. Caan, B. Parker, E. Greenberg, S. Flatt, et al.,
“Influence of a Diet Very High in Vegetables, Fruit, and Fibre and Low
in Fat on Prognosis Following Treatment for Breast Cancer: The
Women’s Healthy Eating and Living (WHEL) Randomized Trial,”
JAMA, 18, 289-98, 2007. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2083253/. (Accsessed 8/12/2014)
[67] Y. Lee, S. Lee, J. Choi, M. Song, H. Sung, S. Jeon, et al., “Prognosis of
breast cancer is associated with one carbon metabolism related nutrients
among Korean women,” Nutrition Journal, 11, 1-9, 2012. Available at:
http://www.nutritionj.com/content/pdf/1475-2891-11-59.pdf. (Accessed
8/12/2014).
[68] A. Harris, L. Bergkvist, and A. Wolk, “Folate intake and breast cancer
mortality in a cohort of Swedish women,” Breast Cancer Research and
Treatment, 132, 243–250, 2011. Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747350/. (Accessed
26/12/2014)
[69] M. Holmes, M. Stampfer, G. Colditz, B. Rosner, D. Hunter, and W.
Willett, “Dietary factors and the survival of women with breast
carcinoma,” Cancer, 86, 826–835, 1999.
[70] E. Rossi, J. Hung, J. Beilby, M. Knuiman, M. Divitini, and H.
Bartholomew, “Folate levels and cancer morbidity and mortality:
prospective cohort study from Busselton, Western Australia,” Annals of
Epidemiology, 16, 206–212, 2006.
[71] Z. Guo, H. Tang, H. Li, S. Tan, K. Feng, Y. Huang, et al., “The Benefits
of psychosocial interventions for Cancer patients undergoing
Radiotherapy,” Health and Quality of Life outcomes, 11, 1-12, 2013.
Available at: http://www.hqlo.com/content/pdf/1477-7525-11-121.pdf.
(Accessed 26/12/2014)
[72] P. Jacobsen, K. Donovan, Z. Swaine, et al., “Management of anxiety and
depression in adult cancer patients: toward an evidence-based
approach,” in A. Chang, P. Ganz, D. Hayes, et al., (eds). Oncology: An
Evidence-Based Approach. New York, NY: Springer-Verlag;
2006:1552–1579 Available at: http://www.cas.usf.edu/~jacobsen/
Anxiety%20depression%20review.pdf (Accessed 8/12/2014).
[73] A. Greer, L. Traeger, H. Bemis, J. Solis, E. Hendriksen, and E. Park, “A
Pilot randomized controlled Trial of Brief Cognitive Behavioural
Therapy for Anxiety in Patients with Terminal Cancer,” The Oncologist,
17, 1337-1345, 2012. Available at: http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3481900/. (Accessed 26/12/2014)
[74] S. Moorey, E. Cort, M. Kapari B. Monroe, P. Hansford, K. Mannix, et
al., “A cluster randomized controlled trial of cognitive behaviour therapy
for common mental disorders in patients with advanced cancer,”
Psychological Medicine, 39, 713–723, 2009.
[75] D. Kissane, B. Grabsch, D. Clarke, G. Smith, A. Love, S. Bloch et al.,
“Supportive‑expressive group therapy for women with metastatic breast
cancer: survival and psychosocial outcome from a randomized
controlled trial 2,” Psychooncology, 16, 277–286, 2007.
[76] D. Spigel, L. Butler, J. Giese-Davis, C. Koopman, E. Miller, S. DiMiceli
et al., “Effects of supportive expressive group Therapy on survival of
patients with metastatic breast cancer,” Cancer, 110, 1130-1138, 2007.
Available at: http://onlinelibrary.wiley.com/doi/10.1002/cncr.22890/full.
(Accessed 25/12/2014)
[77] National Breast Cancer Centre and National Cancer Control Initiative,
“Clinical Practice Guidelines for the psychosocial care of adults with
cancer,” 2003.
[78] M. Holmes, W. Chen, D. Feskanich, C. Kroenke, and G. Colditz,
“Physical activity and survival after breast cancer diagnosis,” JAMA, 25,
293:2479-86, 2005.
[79] A. Meyerhardt, E. Giovannucci, M. Holmes, A. Chan, J. Chan, G.
Colditz, et al, “Physical Activity and Survival After Colorectal Cancer
Diagnosis,” J Clin Oncol, 1, 3527-34, 2006.[80] C. Holick, P. Newcomb, A. Trentham-Dietz, L. Titus-Ernstoff, A.
Bersch, M. Stampfer, et al, “Physical Activity and Survival after
Diagnosis of Invasive Breast Cancer,” Cancer Epidemiology,
Biomarkers & Prevention, 1, 379-86, 2008.
[81] M. Irwin, A. Smith, A. McTiernan, R. Ballard-Barbash, K. Cronin, F.
Gilliland, et al., “Influence of Pre- and Postdiagnosis Physical Activity
on Mortality in Breast Cancer Survivors: The Health, Eating, Activity,
and Lifestyle Study,” Journal of Clinical Oncology, 20, 3958-64, 2008.
[82] Daley, H. Crank, J. Saxton,N. Mutrie, R. Coleman, and A. Roalfe et al.,
“Randomized trial of Exercise Therapy in Women Treated with Breast
Cancer”, Journal of Clinical Oncology, 25, 13, 2007. Available at:
http://jco.ascopubs.org/content/25/13/1713.long. (Accessed 25/12/2014).
[83] Courneya, R. Segal, J. Mackey, K. Gelmon, R. Reid, C. Friedenreich, et
al., “Effects of Aerobic and Resistance Exercise in Breast Cancer
Patients receiving Adjuvant Chemotherapy: A Multicentre Randomized
Controlled Trial,” Journal of Clinical Oncology, 25, 4396-4404, 2007.
[84] Courneya, J. Mackey, G. Bell, L. Jones, C. Field, and A. Fairey,
“Randomized controlled trial of exercise training in postmenopausal
breast cancer survivors: Cardiopulmonary and quality of life outcomes,”
Journal of Clinical Oncology, 21, 1660-1668, 2003. Available at:
http://www.cebp.nl/media/m542.pdf. (Accessed 25/12/2014)
[85] P. Fobair, S. Stewart, S. Chang, C. Onofrio, P. Banks, and J. Bloom,
“Body image and sexual problems in young women with breast cancer,”
Psychooncology, 15, 579-594, 2006.
[86] McNeely, K. Campbell, B. Rowe, T. Klassen, J. Mackey, K. Courneya,
“Effects of Exercise on Breast Cancer Patients and Survivors; a
systematic review and meta-analysis,” CMAJ, 175, 34-41, 2006.
[87] V. Conn, A. Hafdahl, D. Porock, R. McDaniel, and P. Nielsen, “A meta
analysis of exercise interventions among people treated for cancer,”
Supportive Care in Cancer, 14, 699-712, 2006
[88] K. Schmitz, J. Holtzman, K. Courneya, L. Masse, S. Duval, R. Kane,
“Controlled physical activity trials in cancer survivors: A systematic
review and meta-analysis,” Cancer Epidemiology Biomarkers &
Prevention, 14, 1588-1595, 2005. Available at:
http://cebp.aacrjournals.org/content/14/7/1588.long. (Accessed
25/12/2014).
[89] A. Moadel, C. Shah, J. Wylie-Rosett, M. Harris, S. Patel, and C. Hall, et
al., “Randomized controlled Trial of Yoga among a multiethnic sample
of breast cancer patients: Effects on Quality of Life,” Journal of Clinical
Oncology, 25, 2007
[90] S. Culos-Reed, L. Carlson, L. Daroux, and S. Hately, “A pilot study of
yoga for breast cancer survivors:Physical and psychological benefits,”
Psychooncology, 15, 891-897, 2006.
[91] R. Segal, R. Reid, K. Courneya, R. Sigal, G. Kenny, D. Homme, et al.,
“Randomized Controlled Trial of Resistance or Aerobic Exercise in Men
Receiving Radiation Therapy for Prostate Cancer,” Journal of Clinical
Oncology, 27, 344-351, 2009.
[92] P. Windsor, K. Nicol, and J. Potter, “A randomized, controlled trial of
aerobic exercise for treatment related fatigue in men receiving radical
external beam radiotherapy for localized prostate carcinoma,” Cancer,
101, 550-557, 2004.
[93] Culos-Reed SN, Robinson JL, Lau H, K. O’Connor, and M. Keats,
“Benefits of a physical activity intervention for men with prostate
cancer,” Journal of Sport & Exercise Psychology, 29,118- 127, 2007
[94] B. Jereczek-Fossa, H. Marsiglia, and R. Orecchia, “Radiotherapy-related
fatigue,” Critical Reviews in Oncol Hematology, 41:317-325, 2002
[95] C. Bennett, S. Silver, B. Djulbegovic, A. Samaras, C. Blau, K. Gleason,
et al., “Venous thromboembolism and mortality associated with
recombinant erythropoietin and darbepoetin administration for the
treatment of cancer associated anemia,” JAMA, 299, 914-924, 2008.
[96] J. Lemieux, A. Topp, H. Chappell, M. Ennis, and P. Goodwin,
“Economic analysis of psychosocial group therapy in women with
metastatic breast cancer,” Breast Cancer Research and Treatment,
100,183-190, 2006.
[97] S. Hayes, R. Spence, D. Galvão, and R. Newton, “Australian
Association for Exercise and Sport Science position stand: Optimising
cancer outcomes through exercise,” Journal of Science and Medicine in
Sport, 12, 428-34, 2009.
[98] Minton, A. Berger A, A. Barsevick, F. Cramp, M. Goedendorp, S.
Mitchell, et al., “Cancer-related fatigue and its impact on functioning,”
Cancer, 119, 2124–30, 2013.
[99] L. Whitehead, “The measurement of fatigue in chronic illness: a
systematic review of unidimensional and multidimensional fatigue
measures,” J Pain Symptom Manage, 37, 107–28, 2009.
[100]A. Aaronson, V. Mattioli, O. Minton, J. Weis, C. Johansen, S. Dalton, et
al., “Beyond Treatment-Psychosocial and behavioural issues in cancer
survivorship research and practice,” EJC Supplements, 12, 54-64, 2014.
[101] W. Linden, and A. Girgis, “Psychological treatment outcomes for
cancer patients: what do meta-analyses tell us about distress reduction?,”
Psychooncology, 2012;21(4):343–50
[102] K. Boyes, L. Hodgkinson, Alridge, and J. Turner, “Issues for Cancer
Survivors in Australia,” Cancer Forum, 33, 164-167, 2009.
[103] J. Bloom, R. Hoppe, P. Fobair , R. Cox, A. Varghese, D. Spiegel,
“Effects of treatment on the work experiences of long-term survivors of
Hodgkin’s disease,” Journal of Psychosocial Oncology, 1989, 6, 65-80.
Available at: http://www.tandfonline.com/doi/abs/10.1300/
J077v06n03_05?journalCode=wjpo20#.VKZFuXtrJOY. (Accessed
02/01/2015)
[104]Wingard JR, Curbow B, Baker F, Piantadosi S. Health, functional status,
and employment of adult survivors of bone marrow transplantation. Ann
Intern Med. 1991;114:113-118.
[105]S. Schagen, M. Muller, W. Boogerd, G. Mellenbergh, and F. van Dam,
“Change in cognitive function after chemotherapy: a prospective
longitudinal study in breast cancer patients,” Journal of National Cancer
Institute, 98, 1742-1745, 2006. Available at:
http://jnci.oxfordjournals.org/content/98/23/1742.long. (Accessed
25/12/2014).
[106]D. Coward, “Supporting Health Promotion in Adults with Cancer,”
Family & Community Health, 19, 52S-60S, 2005.
[107]L. Forsythe, E. Kent, K. Weaver, N. Buchanan, N. Hawkins, J.
Rodriguez, “Receipt of Psychosocial care among Cancer Survivors in
the United States,” Journal of Clinical Oncology, 31, 1961-69.
[108]J. Guidry , L. Aday, D. Zhang, and R. Winn, “The role of informal and
formal social support networks for patients with cancer,” Cancer
Practice, 5, 241–246, 1997.
[109]A. Leis, C. Haines, and G. Pancyr, “Exploring oncologists’ beliefs about
psychosocial groups: implications for patient care and research,” Journal
of Psychosocial Oncology, 12, 77–87, 1994.
@article{"International Journal of Medical, Medicine and Health Sciences:68988", author = "A. Taqaddas", title = "Assessing Chemo-Radiotherapy Induced Toxicity and Quality of Life of Cancer Patients", abstract = "Chemotherapy and radiotherapy are one of the major
treatment modalities that play important role in the management of a
number of different cancers. This study for the first time evaluates the
toxicity of these treatment modalities and its impact on quality of life
of cancer patients in Pakistan. The study also for the first time
determines what cancer patients of different ages and cancer stages
believe would be an effective intervention to manage their
psychosocial needs and treatment induced toxicity. The article also
provides evidence based approach for the use of variety of
interventions to mange cancer treatment induced morbidity and
toxicity. In light of the present study and reviewed research data,
evidence based recommendations are also made for selection of
appropriate interventions to manage Pain, Nausea and Vomiting,
Anxiety and Depression, Fatigue and Overall QOL of cancer
survivors.
", keywords = "Chemotherapy Toxicity, Psycho-Social
Interventions, Quality of Life, Radiotherapy Toxicity.", volume = "9", number = "1", pages = "59-23", }
